These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 350535)

  • 1. [Pharmacokinetics of ticarcillin in patients with normal and impaired renal function (author's transl)].
    Höffler D; Dalhoff A; Koeppe P
    Dtsch Med Wochenschr; 1978 Jun; 103(22):931-5. PubMed ID: 350535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of ticarcillin in the dog.
    Tilmant L; Brown MP; Gronwall RR
    Am J Vet Res; 1985 Feb; 46(2):479-81. PubMed ID: 3922261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic studies on clavulanate potentiated ticarcillin in normal subjects and patients with renal insufficiency.
    Koeppe P; Höffler D; Hulla FW
    Arzneimittelforschung; 1987 Feb; 37(2):203-8. PubMed ID: 3580024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ticarcillin in the horse after intravenous and intramuscular administration.
    Sweeney CR; Soma LR; Beech J; Reef V; Simmons R
    Am J Vet Res; 1984 May; 45(5):1000-2. PubMed ID: 6732002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of intravenous mezlocillin in patients with normal and impaired renal function (author's transl)].
    Cano JP; Rigault JP; Gevaudan MJ; Saingra S; Murisasco A; Charpin J
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):335-9. PubMed ID: 6460972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cefamandol: pharmacokinetics with normal and impaired renal function (author's transl)].
    Höffler D; Moecke D; Sassmann M
    Dtsch Med Wochenschr; 1978 Aug; 103(34):1334-8. PubMed ID: 679835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and endometrial tissue concentrations of ticarcillin given to the horse by intravenous and intrauterine routes.
    Spensley MS; Baggot JD; Wilson WD; Hietala SK; Mihalyi JE
    Am J Vet Res; 1986 Dec; 47(12):2587-90. PubMed ID: 3800116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of azlocillin in healthy subjects.
    Leroy A; Humbert G; Fillastre JP
    Scand J Infect Dis Suppl; 1981; 29():49-54. PubMed ID: 6947405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics of intramuscular mezlocillin in patients with normal and impaired renal function (author's transl)].
    Brogard JM; Comte F; Kopferschmitt J; Dorner M; Lavillaureix
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):340-6. PubMed ID: 6460973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of Cefmenoxime in normal and impaired renal function.
    Höffler D; Koeppe P
    Arzneimittelforschung; 1983; 33(2):269-72. PubMed ID: 6303362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ceftazidime in normal and impaired renal function.
    Höffler D; Koeppe P; Williams KJ
    Arzneimittelforschung; 1984; 34(1):72-6. PubMed ID: 6367755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
    Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
    Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenously and intramuscularly administered ticarcillin and clavulanic acid in foals.
    Sweeney RW; Beech J; Simmons RD
    Am J Vet Res; 1988 Jan; 49(1):23-6. PubMed ID: 3354961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of parenteral ticarcillin formulated with clavulanic acid: Timentin.
    Staniforth DH; Coates PE; Davies BE; Horton R
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):123-9. PubMed ID: 3699938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis.
    Kosmidis J; Doundoulaki P; Stathakis C; Zerefos N; Bounia A; Daikos GK
    Arzneimittelforschung; 1979; 29(12a):1960-2. PubMed ID: 543901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the combination of ticarcillin with clavulanic acid in renal insufficiency.
    Dalet F; Amado E; Cabrera E; Donate T; del Rio G
    J Antimicrob Chemother; 1986 May; 17 Suppl C():57-64. PubMed ID: 3722047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)].
    Ohnhaus EE; Spring P; Dettli L
    Dtsch Med Wochenschr; 1974 Sep; 99(37):1797-803. PubMed ID: 4457307
    [No Abstract]   [Full Text] [Related]  

  • 18. Ticarcillin: pharmacokinetics in man according to different administration schedules.
    Dalhoff A; Höffler D
    J Int Med Res; 1977; 5(5):308-21. PubMed ID: 913858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the pharmacokinetics of latamoxef in normal and impaired renal function.
    Höffler D; Koeppe P; Moecke D
    Arzneimittelforschung; 1984; 34(3):317-20. PubMed ID: 6539614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ticarcillin in patients with abnormal renal function.
    Parry MF; Neu HC
    J Infect Dis; 1976 Jan; 133(1):46-9. PubMed ID: 1107435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.